ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Metagenomi Inc

Metagenomi Inc (MGX)

5.14
0.50
(10.78%)
Closed July 13 4:00PM
5.10
-0.04
(-0.78%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.14
Bid
4.80
Ask
5.47
Volume
151,572
4.69 Day's Range 5.4999
3.34 52 Week Range 12.74
Market Cap
Previous Close
4.64
Open
4.69
Last Trade
4
@
5.19
Last Trade Time
Financial Volume
$ 780,401
VWAP
5.1487
Average Volume (3m)
104,381
Shares Outstanding
37,464,201
Dividend Yield
-
PE Ratio
-2.80
Earnings Per Share (EPS)
-1.82
Revenue
44.76M
Net Profit
-68.26M

About Metagenomi Inc

At Metageno­mi, we are cre­at­ing poten­tial­ly cura­tive ther­a­peu­tics using our metage­­nomics-pow­ered genome edit­ing toolbox.We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of geno... At Metageno­mi, we are cre­at­ing poten­tial­ly cura­tive ther­a­peu­tics using our metage­­nomics-pow­ered genome edit­ing toolbox.We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing asuite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was $4.64. Over the last year, Metagenomi shares have traded in a share price range of $ 3.34 to $ 12.74.

Metagenomi currently has 37,464,201 shares outstanding. The market capitalization of Metagenomi is $173.83 million. Metagenomi has a price to earnings ratio (PE ratio) of -2.80.

MGX Latest News

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

EMERYVILLE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational development program in Hemophilia A; development candidate nomination anticipated in mid-year...

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

EMERYVILLE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi to Present at Upcoming Scientific Meetings

-   Oral Presentation at World Federation of Hemophilia (WFH) World Congress, April 23, 2024 -   Two Posters at American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, May 8 &...

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.2632.47422680413.885.49993.81422454.39461127CS
4-0.86-14.333333333366.2473.341137664.05504968CS
12-2.53-32.98565840947.678.3953.341043815.74385118CS
26-5.11-49.853658536610.2512.743.341470799.00041443CS
52-5.11-49.853658536610.2512.743.341470799.00041443CS
156-5.11-49.853658536610.2512.743.341470799.00041443CS
260-5.11-49.853658536610.2512.743.341470799.00041443CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Your Recent History

Delayed Upgrade Clock